Does a correlation exist between delayed vaccination and a decreased vaccine confidence?

Autor: Reverte V; Health Prevention and Protection Service, General Directorate of Public Health and Addictions, Murcia, Region of Murcia, Spain., Zornoza-Moreno M; Health Prevention and Protection Service, General Directorate of Public Health and Addictions, Murcia, Region of Murcia, Spain., Molina-Salas YE; Lorca Public Health Service, General Directorate of Public Health and Addictions, Lorca, Region of Murcia, Spain., Romera-Guirado FJ; Lorca Public Health Service, General Directorate of Public Health and Addictions, Lorca, Region of Murcia, Spain., Celdrán-Navarro MDC; Mazarrón Primary Health Care Center, Murcian Health Service, Murcia, Region of Murcia, Spain., Pérez-Martín JJ; Health Prevention and Protection Service, General Directorate of Public Health and Addictions, Murcia, Region of Murcia, Spain.

Publikováno v: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2419750. Date of Electronic Publication: 2024 Oct 27.

Parental knowledge on the respiratory syncytial virus before the nirsevimab immunization program: Attitudes toward immunization in an autonomous community of Spain.

Autor: Zornoza Moreno M; Prevention and Health Protection Service. Public Health and Addictions Directorate General, Regional Ministry of Health, Murcia, Spain., Pérez Martín JJ; Prevention and Health Protection Service. Public Health and Addictions Directorate General, Regional Ministry of Health, Murcia, Spain., Moreno MCG; Prevention and Health Protection Service. Public Health and Addictions Directorate General, Regional Ministry of Health, Murcia, Spain., Abellán MPR; Prevention and Health Protection Service. Public Health and Addictions Directorate General, Regional Ministry of Health, Murcia, Spain.

Publikováno v: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2357439. Date of Electronic Publication: 2024 Jun 10.

Adverse Effects Related to Paediatric Influenza Vaccination and Its Influence on Vaccination Acceptability. The FLUTETRA Study: A Survey Conducted in the Region of Murcia, Spain.

Autor: Zornoza Moreno M; Prevention and Health Protection Service, Ministry of Health, Murcia, Spain., Pérez Martín JJ; Prevention and Health Protection Service, Ministry of Health, Murcia, Spain., Gómez Moreno MC; Prevention and Health Protection Service, Ministry of Health, Murcia, Spain., Valcárcel Gómez MDC; Prevention and Health Protection Service, Ministry of Health, Murcia, Spain., Pérez Martínez M; Prevention and Health Protection Service, Ministry of Health, Murcia, Spain., Tornel Miñarro FI; Prevention and Health Protection Service, Ministry of Health, Murcia, Spain.

Publikováno v: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024 Jun; Vol. 18 (6), pp. e13331.

Effectiveness of Modified Vaccinia Ankara-Bavaria Nordic Vaccination in a Population at High Risk of Mpox: A Spanish Cohort Study.

Autor: Fontán-Vela M; National Centre of Epidemiology, Institute of Health Carlos III, Community of Madrid, Spain.; Public Health and Epidemiology Research Group, School of Medicine and Health Sciences, Universidad de Alcalá, Alcalá de Henares, Community of Madrid, Spain., Hernando V; National Centre of Epidemiology, Institute of Health Carlos III, Community of Madrid, Spain.; CIBER on Infectious Diseases, Madrid, Spain., Olmedo C; Vaccination Programme, General Directorate of Public Health, Ministry of Health, Madrid, Spain., Coma E; Primary Healthcare Information Systems, Health Institute of Catalonia, Catalonia, Spain., Martínez M; Preventive Medicine Service, General Sub-directorate for Health Promotion, Health Department, Secretariat of Public Health,Catalonia, Spain., Moreno-Perez D; Health and Consumption Department, General Directorate of Public Health and Pharmaceutical Management, Andalusia, Spain., Lorusso N; Health and Consumption Department, General Directorate of Public Health and Pharmaceutical Management, Andalusia, Spain., Vázquez Torres M; Healthcare Department, General Sub-directorate of Health Prevention and Promotion, General Directorate of Public Health, Community of Madrid, Spain., Barbas Del Buey JF; General Sub-directorate of Public Health Surveillance, General Directorate of Public Health, Madrid, Community of Madrid, Spain., Roig-Sena J; Department of Universal Healthcare and Public Health, Epidemiological Surveillance Service, Valencian Community, Spain., Pastor E; Universal Healthcare and Public Health Department, Health Promotion and Prevention Programs Service, Valencian Community, Spain., Galmés Truyols A; Disease Prevention Service, Health and Consumption Department, General Directorate of Public Health and Participation, Balearic Islands, Spain., Artigues Serra F; Disease Prevention Service, Health and Consumption Department, General Directorate of Public Health and Participation, Balearic Islands, Spain., Sancho Martínez RM; Epidemiology Unit, General Sub-directorate of Public Health and Addictions of Gipuzkoa, Basque Country, Spain., Latasa Zamalloa P; Epidemiology and Vaccination Service, General Directorate of Public Health, Basque Country, Spain., Pérez Martínez O; Epidemiology Service, Health Department, General Directorate of Public Health, Galicia, Spain., Vázquez Estepa A; Epidemiology Service, Health Department, General Directorate of Public Health, Galicia, Spain., García Rojas AJ; Prevention and Epidemiology Service, General Directorate of Public Health, Canarian Health Service, Canary Islands, Spain., Barreno Estévez AI; Prevention and Epidemiology Service, General Directorate of Public Health, Canarian Health Service, Canary Islands, Spain., Sánchez-Migallón Naranjo A; Epidemiology Service, Health Department, General Directorate of Public Health and Addictions, Murcia Region, Spain., Pérez Martín JJ; Vaccination Progamme, Prevention and Health Protection Service, Health Department, General Directorate of Public Health and Addictions, Murcia Region, Spain., Peces Jiménez P; Epidemiology Service, Healthcare Department, General Directorate of Public Health, Castilla-La Mancha, Spain., Morales Romero R; Epidemiology Service, Healthcare Department, General Directorate of Public Health, Castilla-La Mancha, Spain., Castilla J; Instituto de Salud Pública de Navarra - IdiSNA - CIBERESP, Pamplona, Spain., García Cenoz M; Instituto de Salud Pública de Navarra - IdiSNA - CIBERESP, Pamplona, Spain., Huerta Huerta M; Vaccination Programme, Health Department, Epidemiological Surveillance Service, Principado de Asturias, Spain., Boone ALD; Vaccination Programme, Health Department, Epidemiological Surveillance Service, Principado de Asturias, Spain., Macías Ortiz MJ; Vaccination Program, General Directorate of PublicHealth, Healthcare Service of Extremadura, Spain., Álvarez Río V; Epidemiology Service, Healthcare Department, General Directorate of Public Health, Castilla y León, Spain., Rodríguez Recio MJ; Epidemiology Service, Healthcare Department, General Directorate of Public Health, Castilla y León, Spain., Merino Díaz M; Epidemiology and Healthcare Prevention Service, Health Department, General Directorate of Public Health, Consumption and Nursing, La Rioja, Spain., Berradre Sáenz B; Epidemiology and Healthcare Prevention Service, Health Department, General Directorate of Public Health, Consumption and Nursing, La Rioja, Spain., Villegas-Moreno MT; National Centre of Epidemiology, Institute of Health Carlos III, Community of Madrid, Spain., Limia A; Vaccination Programme, General Directorate of Public Health, Ministry of Health, Madrid, Spain., Diaz A; National Centre of Epidemiology, Institute of Health Carlos III, Community of Madrid, Spain.; CIBER on Infectious Diseases, Madrid, Spain., Monge S; National Centre of Epidemiology, Institute of Health Carlos III, Community of Madrid, Spain.; CIBER on Infectious Diseases, Madrid, Spain.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Feb 17; Vol. 78 (2), pp. 476-483.

Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024.

Autor: López-Lacort M; Vaccine Research Department, Fisabio-Public Health, Valencia, Spain.; These authors contributed equally to this article and share first authorship.; CIBERESP, Instituto de Salud Carlos III, Madrid, Spain., Muñoz-Quiles C; Vaccine Research Department, Fisabio-Public Health, Valencia, Spain.; These authors contributed equally to this article and share first authorship.; CIBERESP, Instituto de Salud Carlos III, Madrid, Spain., Mira-Iglesias A; Vaccine Research Department, Fisabio-Public Health, Valencia, Spain.; CIBERESP, Instituto de Salud Carlos III, Madrid, Spain., López-Labrador FX; CIBERESP, Instituto de Salud Carlos III, Madrid, Spain.; Virology Laboratory, Fisabio-Public Health, Valencia, Spain.; Department of Microbiology and Ecology, Medical School, University of Valencia, Valencia, Spain., Mengual-Chuliá B; CIBERESP, Instituto de Salud Carlos III, Madrid, Spain.; Virology Laboratory, Fisabio-Public Health, Valencia, Spain., Fernández-García C; Vaccine Research Department, Fisabio-Public Health, Valencia, Spain., Carballido-Fernández M; Hospital General Universitario de Castellón, Castellón, Spain.; Medicine Department, Universidad CEU Cardenal Herrera, Castellón de la Plana, Spain., Pineda-Caplliure A; Hospital Universitario Dr. Peset, Valencia, Spain., Mollar-Maseres J; Hospital Universitario La Fe, Valencia, Spain., Shalabi Benavent M; Hospital Marina Baixa, Alicante, Spain., Sanz-Herrero F; Hospital General Universitario, Valencia, Spain., Zornoza-Moreno M; Murcia Health Council, Murcia, Spain., Pérez-Martín JJ; Murcia Health Council, Murcia, Spain., Alfayate-Miguelez S; Murcia Health Council, Murcia, Spain., Pérez Crespo R; Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain., Bastida Sánchez E; Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain., Menasalvas-Ruiz AI; Hospital General Universitario Santa Lucía, Murcia, Spain., Téllez-González MC; Hospital General Universitario Santa Lucía, Murcia, Spain., Esquiva Soto S; Hospital General Universitario Santa Lucía, Murcia, Spain., Del Toro Saravia C; Hospital Rafael Méndez, Murcia, Spain., Sanz-Muñoz I; National Influenza Centre, Valladolid, Spain., Eiros JM; National Influenza Centre, Valladolid, Spain., Matías Del Pozo V; Hospital Clínico, Valladolid, Spain., Toquero-Asensi M; Hospital Clínico, Valladolid, Spain., Pastor-Villalba E; Dirección General de Salud Pública, Valencia, Spain., Lluch-Rodrigo JA; Dirección General de Salud Pública, Valencia, Spain., Díez-Domingo J; Vaccine Research Department, Fisabio-Public Health, Valencia, Spain.; Catholic University of Valencia, Valencia, Spain.; CIBERESP, Instituto de Salud Carlos III, Madrid, Spain., Orrico-Sánchez A; Vaccine Research Department, Fisabio-Public Health, Valencia, Spain.; Catholic University of Valencia, Valencia, Spain.; CIBERESP, Instituto de Salud Carlos III, Madrid, Spain.

Publikováno v: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2024 Feb; Vol. 29 (6).